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ABSTRACT 
The 5ʹUTR of the HIV-1 genomic RNA (gRNA) contains a structured RNA element (termed 
Psi) that is specifically recognized through the interaction with the nucleocapsid (NC) domain of 
HIV-1 Gag, ensuring that two copies of gRNA are packaged into newly assembled virions. 
However, the mechanism by which Gag recognizes gRNA over other cellular RNAs and spliced 
RNAs is not well understood. Exposed guanosine residues within the loops and bulges of Psi have 
been shown to be high affinity NC binding sites, providing a selective advantage for gRNA. 
Furthermore, a recent study suggested that a negative regulatory element upstream of Psi 
reduces high-affinity Gag binding, and a positive downstream regulatory element counteracts 
the upstream element and restores high-affinity binding. These elements are proposed to form 
a long-range interaction that promotes packaging of only full-length gRNA and excludes 
packaging of spliced RNAs. Using a fluorescence anisotropy-based salt-titration binding assay, 
which measures the electrostatic and nonelectrostatic (i.e., specific) components of protein 
binding RNA, we have previously shown that Gag interacts with a 109 nt Psi RNA construct with 
high specificity and relatively few electrostatic interactions. High specificity of this Psi construct 
is maintained when guanosine residues in the bulges of SL2 are mutated, but guanosine 
mutations in the bulges of SL1 and regions downstream of SL3 greatly diminish this high 
specificity. When using a 356-nt RNA construct that now includes the upstream negative 
regulatory element in addition to Psi, we observed similar Gag binding specificity and 
electrostatic interactions to the 109 nt WT Psi construct. However, a 400 nt construct that 
additionally contains the positive element, increased specific binding and reduced the 
electrostatic interactions. Interestingly, Gag binding specificity remained high even in constructs 
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wherein the 44 nt of the downstream positive regulatory element were scrambled. Thus, while 
the presence of downstream sequences is important for high-specificity Gag binding, their 
identity is not. Furthermore, the secondary structures of spliced RNA constructs were probed via 
selective 2ʹ hydroxyl acylation analyzed by primer extension (SHAPE) to study how they prevent 
specific packaging. In a construct composed of the first 400 nt of the Vpr mRNA, destabilization 
of the polyA hairpin was observed which has been shown to be critical for RNA packaging and 
viral replication. Meanwhile, the secondary structure of a construct containing the first 400 nt of 
the Tat mRNA displays a sequestered primer binding site (PBS) which has been shown to be 
necessary for tRNALys3 annealing and initiation of reverse transcription. Altogether, these results 
allow us to better understand the mechanism by which genomic RNA packaging occurs.  
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INTRODUCTION 
According to the World Health Organization, approximately 37 million people are 
currently infected by the Human Immunodeficiency Virus type 1 (HIV-1) worldwide, making it 
one of the most critical global health issues of today. A vaccine or cure for HIV-1 have yet to be 
developed, but with the advent of highly active antiretroviral therapy (HAART) the disease has 
been rendered into a manageable infection. HAART combines a variety of antiretroviral drugs 
that block HIV-1 replication. As a result of HAART, many treated patients are able to live healthy 
lives, symptom-free. However, the continuous use of antiretroviral medication may have other 
adverse effects and drives the risk of emergence of drug-resistant strains, thus forcing the 
continuous development of novel antiretroviral drugs. These drugs target many different stages 
in the HIV-1 retroviral lifecycle which include fusion, reverse transcription, integration, and 
maturation (Figure 1). Interestingly, there are no current antiretroviral drugs that target HIV-1 
packaging and assembly, making it of significant interest in our lab and others.  
 
FIGURE 1: HIV-1 Lifecycle. Targets of current antiretroviral medications are highlighted in red (Musumeci, Riccardi 
and Montesarchio 2015). 
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A hallmark of retroviruses is their ability to reverse transcribe single-stranded genomic 
RNA (gRNA) into double-stranded DNA for subsequent integration into the host cell genome. 
Following nuclear transcription and export into the cytoplasm, highly selective packaging of the 
full-length, unsliced gRNA into newly assembled virus particles is achieved, despite the presence 
of spliced viral RNA and a vast excess of cellular RNA (Berkowitz, Fisher and Goff 1996, 
Kuzembayeva et al. 2014). HIV-1 packages only a single, dimeric copy of its gRNA (Rein et al. 2011, 
Moore and Hu 2009, Chen et al. 2009, Nikolaitchik et al. 2013). Specific interactions between the 
HIV-1 5’ untranslated Region (5ʹUTR) and the Gag protein are critically involved in this specific 
packaging and assembly step of budding virions. The 5ʹUTR is the most highly conserved region 
in the viral genome and is also responsible for numerous aspects of viral life cycle regulation. It 
is comprised of the trans-activation response (TAR) stem loop, the poly-A hairpin, the primer 
binding site (PBS) domain, and the four stem loops (SL1-SL4) of the “Psi” (Ψ) packaging signal. 
The TAR stem loop is involved in viral RNA transcription upregulation (Bannwarth and Gatignol 
2005),  and the PBS domain contains the site where tRNALys,3, the reverse transcription primer, 
anneals (Mak and Kleiman 1997, Goldschmidt et al. 2002). SL1 contains the genomic RNA (gRNA) 
dimerization initiation site (DIS), SL2 is the major 5ʹ splice donor, SL3 is a high-affinity Gag binding 
site, and SL4 harbors the Gag gene start codon. The 5ʹUTR is also known to adopt multiple 
conformations allowing for preferential selection by HIV-1 Gag (Heng et al. 2012, Abbink and 
Berkhout 2003).  
Experimental data suggest that the NC domain of Gag interacts with the gRNA in the 
5ʹUTR at Psi. Specific HIV-1 gRNA packaging is achieved, in part, via the interaction between the 
nucleocapsid (NC) domain of the HIV-1 Gag polyprotein and Psi (Heng et al. 2012, Kutluay et al. 
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2014). In addition to the NC domain, HIV-1 Gag consists of matrix (MA), capsid (CA), two spacer 
peptides, and p6 (Figure 2). In the context of the polyprotein, MA targets the assembling virus to 
the plasma membrane (PM) (Chukkapalli and Ono 2011), CA is involved in Gag multimerization 
associated with immature viral particle formation (Datta and Rein 2009, Schur et al. 2015), NC 
functions as a nucleic acid chaperone in addition to its role in gRNA packaging (Levin et al. 2005, 
D'Souza and Summers 2005, Lu, Heng and Summers 2011, Feng et al. 1999, Jones et al. 2011, 
Cristofari and Darlix 2002, Rein, Henderson and Levin 1998), and the p6 domain recruits factors 
required for viral fission from the cell (Martin-Serrano and Neil 2011, Meng and Lever 2013). 
Importantly, the main structural domains of Gag provide functional redundancy to ensure proper 
viral assembly through Gag-nucleic acid, Gag-Gag, and Gag-membrane interactions (O'Carroll et 
al. 2012, O'Carroll et al. 2013).  
Furthermore, HIV-1 Gag has been shown to adopt multiple conformations	 in solution 
(Datta et al. 2011, Munro et al. 2014).  One of the key functions of Gag is to ensure that the two 
strands of gRNA are properly incorporated into the new virions. However, the precise mechanism 
Gag employs to select two copies of gRNA over the vast excess of host and non-genomic viral 
RNA remains an open question. In this thesis, using in vitro biochemical techniques, I will 
FIGURE 2. HIV-1 Gag∆p6 construct used in this work with full-length wild-type (WT) Gag shown at the top of each 
set for comparison.  
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investigate the structural elements within the HIV-1 5’UTR that we hypothesize regulate specific 
Gag binding. This work will improve our understanding of HIV-1 gRNA packaging and may uncover 
new avenues for rational drug design.  
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CHAPTER 1: CRITICAL GUANOSINE RESIDUES IN HIV-1 PSI ARE REQUIRED FOR 
SPECIFIC RECOGNITION BY HIV-1 GAG∆P6 
INTRODUCTION 
Although the minimal element that is both necessary and sufficient to confer selective 
HIV-1 gRNA packaging is not yet known, a gRNA packaging competition assay has defined a “core 
encapsidation signal” composed of the U5 region and stem-loops 1-4 (SL1-SL4) of Psi (Heng et al. 
2012). In the absence of Psi, efficient virion formation still occurs and cellular RNAs are 
incorporated into virions at levels corresponding to their relative amounts in the cytoplasm (Rulli 
et al. 2007). This indicates that Psi provides a “packaging advantage” to gRNA, and in the absence 
of this signal, random RNAs are passively incorporated into viral particles. Within the stem-loops 
that constitute Psi, exposed G residues in loops and bulges have been shown to be high-affinity 
NC binding sites based on a number of lines of evidence including selective 2’-hydroxyl analyzed 
by primer extension (SHAPE) footprinting studies of gRNA in virions (Wilkinson et al. 2008), in 
vitro RNA binding and footprinting assays (Keane et al. 2015, Abd El-Wahab et al. 2014), and 
crosslinking-immunoprecipitation-sequencing (CLIP-seq) techniques in HIV-1 infected cells 
(Kutluay et al. 2014).  
Several factors in addition to Gag/NC binding affinity to Psi have recently been proposed 
to play a role in selective gRNA packaging. In vitro fluorescence-anisotropy (FA) salt-titration 
binding assays showed that HIV-1 Gag binding to RNA derived from the gRNA Psi region is 
characterized by highly specific non-electrostatic binding and an effective charge that is 
consistent with an NC-only binding mode (Webb et al. 2013). In contrast, binding to a non-Ψ RNA 
is characterized by less specific binding and a higher effective charge, consistent with nucleic acid 
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binding by both NC and MA domains. Thus, changes in Gag’s binding conformation may 
contribute to the high degree of discrimination between Psi and non-Psi RNA (Webb et al. 2013).  
As mentioned earlier, previous FA salt-titration binding assays provided insights into 
specific Psi RNA recognition by HIV-1 Gag (Webb et al. 2013). Two key parameters are obtained 
using this approach, Kd(1M), which describes the non-electrostatic component of binding (i.e., the 
extrapolated dissociation constant at 1 M salt), and Zeff, the effective charge of the protein–
nucleic acid interaction, which is the number of Na+ cations displaced upon nucleic acid binding 
(Rye-McCurdy, Rouzina and Musier-Forsyth 2015). We previously reported that HIV-1 Gag binds 
to Psi RNA with a dramatically reduced Kd(1M) and lower Zeff relative to a non-Psi RNA (TARpolyA). 
These results suggest that Gag interacts with RNA using different binding modes; both the NC 
and MA domains bind to RNA in the case of TARpolyA, whereas binding to Psi RNA preferentially 
involves the NC domain at the expense of MA interactions. Mutations altering the NC zinc finger 
motifs of Gag significantly reduce the non-electrostatic component of binding to Psi RNA and lead 
to an increase in Zeff. Surprisingly, the specific binding of Gag to Psi also depended on the 
presence of the MA domain, as a Gag variant lacking MA was less able to discriminate Psi from 
non-Psi RNA and bound both RNAs with similar overall charge (Webb et al. 2013). We now 
investigated the RNA elements that contribute to specific recognition of Psi. 
MATERIALS AND METHODS 
PROTEIN PREPARATION 
The plasmid encoding HIV-1 Gag∆p6 was a gift from Dr. Alan Rein (HIV Dynamics and 
Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, 
USA). HIV-1 Gag∆p6 was expressed and purified using established methods (Datta and Rein 
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2009). Protein concentrations were determined from the absorbance at 280 nm using the 
following molar extinction coefficient for HIV-1 Gag∆p6:  63,090 M−1·cm−1. 
RNA PREPARATION 
All RNA constructs were in vitro transcribed from linearized plasmids using T7 RNA 
polymerase and previously established methods (Milligan et al. 1987) (Figures 3A). The HIV-1 Ψ-
WT RNA construct was derived from nt 229–338 and the TARpolyA RNA construct was derived 
from nt 1–104 of the HIV-1 NL4-3 genome (Adachi et al. 1986). Plasmids encoding both RNAs 
contain FokI restriction enzyme cut sites to generate the correct 3ʹ end of the RNA. All HIV-1 Ψ 
RNA variants were designed with 2 additional G residues at the 5ʹ end to promote efficient T7-
mediated transcription. HIV-1 Ψ-Mut 1 (G241,242A), Ψ-Mut 2 (G274,275A), Ψ-Mut 3 (G292A, 
U293A, G294A), Ψ-Mut 4 (G311A), Ψ-Mut 5 (G319A, G321A), Ψ-Mut 6 (G329,330A), Ψ-Mut 7 
(G235A), and Ψ-Mut 8 (G267,268A) were prepared from the HIV-1 Ψ-WT template plasmid 
using QuikChange (Agilent Technologies, Santa Clara, CA, USA) or site-directed ligase-
independent mutagenesis (SLIM) (Chiu et al. 2004).  
FLUORESCENT RNA LABELING 
All RNAs were labeled with fluorescein-5-thiosemicarbazide (FTSC) at the 3ʹ end as 
described (Pagano et al. 2007). The concentration and labeling efficiency were determined by 
measuring the absorbance at 260 nm and 495 nm and using the following molar extinction 
coefficients: ε495nm = 8.5 × 104
 M−1·cm−1 (fluorescein), ε260nm = 9.7 × 105
 M−1·cm−1 (HIV-1 Ψ WT 
and HIV-1 Ψ mutants), and ε260nm = 9.3 × 105
 M−1·cm−1 (HIV-1 TARpolyA).  
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DIRECT FA BINDING ASSAYS 
Direct FA binding assays were performed at 20 mM HEPES pH 7.5, 1 mM MgCl2, 50 mM 
NaCl, and 20.5 nM RNA to obtain a preliminary assessment of binding affinity and to establish 
the concentration of each protein to use in the salt-titration studies as previously described 
(Webb et al. 2013, Rye-McCurdy et al. 2015).  
FA-BASED SALT TITRATION ASSAYS 
FA salt-titration binding assays were carried out using established protocols (Webb et al. 
2013, Rye-McCurdy et al. 2015). Assays were performed with 20.5 nM RNA in 20 mM HEPES or 
Tris-HCl, pH 7.5, 1 mM MgCl2, and 50 mM monovalent ions with 300–400 nM HIV-1 Gag∆p6. All 
fluorescence measurements were performed on a SpectraMax M5 plate reader (Molecular 
Devices, Sunnyvale, CA, USA).  
RESULTS AND DISCUSSION 
In agreement with our previous work (Webb et al. 2013), HIV-1 Gag∆p6 binding to WT Ψ 
RNA was characterized by an ~15,000-fold greater specificity (Kd(1M) = 3.6 x 10-5 M) and ~6 fewer 
electrostatic interactions (Zeff ~ 5) than binding to TARpolyA (Kd(1M) = 5.6 x 10-1 M and Zeff ~ 11) 
(Figure 3C and D). HIV-1 Gag∆p6 exhibited only a minor loss in specificity upon mutation of 
residues in the loops of SL2 and SL3 of HIV-1 Ψ (Mut 3 and 5; Kd(1M) ~ 6-8 x 10-5 M and relative 
specificity of 0.47-0.61 of Ψ-WT), and only a modest increase in the number of electrostatic 
charges mediating the interaction (Zeff ~ 5-6) (Figure 3C and D). Based on the partial overlap of 
the parameter values measured for these mutants with those for Ψ-WT, we conclude that these 
~2-fold differences are not significantly different from WT. Similarly, although a point mutation 
in the single-stranded region between SL2 and SL3 (Mut 4) appeared to lead to a greater loss i
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 HIV-1 Gag∆p6 
RNA Kd(1M) (M) Zeff 
Relative 
Specificity 
TARpolyA (5.6 + 6) x 10 -1 10.5 + 1.0 6.4 x 10-5 
Ψ-WT (3.6 + 2) x 10-5 5.4 + 0.5 1.0 
Ψ -Mut1 (3.4 + 5) x 10-4 6.7 + 1.4 0.11 
Ψ -Mut2 (9.5 + 16) x 10-4 7.1 + 1.4 0.038 
Ψ -Mut3 (5.9 + 4) x 10-5 5.5 + 0.9 0.61 
Ψ -Mut4 (2.6 + 3) x 10-4 6.7 + 2.1 0.14 
Ψ -Mut5 (7.6 + 6) x 10-5 5.9 + 0.6 0.47 
Ψ -Mut6 (4.6 + 3) x 10-4 7.8 + 0.8 0.078 
Ψ –Mut7 (3.7 + 2) x 10-5 5.2 + 0.7 0.97 
Ψ –Mut8 (2.1 + 2) x 10-5 4.4 + 1.2 1.7 
 
FIGURE 3 HIV-1 RNA constructs used in this work and salt-titration binding results with HIV-1 Gag∆p6. (A) Predicted 
secondary structures of HIV-1 Ψ (left) and HIV-1 TARpolyA (right) are shown. Eight mutant Ψ RNAs are indicated by 
the boxed nt and arrows (Mut1-Mut8). Additional 5’ G nt not present in the HIV-1 genome were added to facilitate 
in vitro transcription and are shown in gray. (B) The location of Mut 1-8 mapped onto the all-atom model of HIV-1 
Ψ previously determined from small angle x-ray scattering data and computational modeling. Colors in A and B 
indicate mutations that had no effect on specificity (blue), and significant effects (red) based on salt-titration binding 
assays. Bar graphs of Kd(1M) values (C) and Zeff values (D) determined from salt-titration assays with HIV-1 Gag∆p6 
and HIV-1 TARpolyA, Ψ RNA, and Ψ RNA mutants. Values of three or four trials performed in each case are shown 
with the height of the bar indicating the mean value. Specificity of the WT Ψ RNAs was set to 1.0 and the relative 
specificity of the non-Ψ or mutant Ψ RNAs was calculated as Kd(1M) (Ψ-WT)/ Kd(1M) (Ψ-variant). 
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specificity (Kd(1M) ~ 3 x 10-4 M; relative specificity of 0.14), based on the variability in the data 
generated using this mutant, we conclude that it was not significantly different from Ψ-WT. In 
contrast, a significant loss in specificity was observed upon mutation of residues in the bulge 
regions of SL1 (Mut 1 and 2), as well as in the region downstream of SL3 (Mut 6) (relative 
specificity of 0.04-0.11). The final two HIV-1 Ψ mutants tested (Mut 7 and 8) bound HIV-1 Gag∆p6 
with a relative specificity of 0.97-1.7 and interacted with a similar number of electrostatic 
contacts (Zeff ~ 4-5) as Ψ-WT (Figure 3C and D). While we observed different effects of the HIV-1 
Ψ mutants on Gag binding specificity, no single Ψ mutant diminished specificity to the level of 
non-Ψ RNA. 
FIGURE 4 Native-PAGE of fluorescently-labeled WT and mutant HIV-1 Ψ RNAs. RNAs were labeled as described in 
the main text and folded as follows: 1-5 µM RNA in 50 mM HEPES, pH 7.5, was heated at 80°C for 2 min, then 60°C 
for 2 min, and then MgCl2 was added to a final concentration of 10 mM, followed by incubation on ice for a minimum 
of 30 min. Folded RNAs were run on 8% native-polyacrylamide gels (19:1 acrylamide: bis-acrylamide) also containing 
1 mM MgCl2 and TB (18 mM Tris, 9 mM borate, pH 8) at 4°C in TB running buffer. The final concentration HIV-1 RNA 
run on the gels shown was 20.5 nM. Gels were visualized using the fluorescence mode on an AlphaImager EP 
(AlphaInnotech). 
 
 
 
15 
To determine whether the Ψ mutations disrupted the global RNA fold, all HIV-1 Ψ RNA 
variants were subjected to native-PAGE analysis. The majority of RNAs migrated as a single band 
corresponding to the RNA dimer, and there were no changes in the global conformation of the 
mutants relative to Ψ-WT (Figure 4). The only exception was Mut 8, which was a mix of dimer 
(major band) and monomer (minor band).  
Previous salt-titration binding assays investigated a HIV-1 Ψ variant (Ψ-12M) wherein 12 
single-stranded G bases in loops and bulges (clustered in 6 regions) were simultaneously 
mutated. These regions were proposed to be high-affinity NC binding sites based on a SHAPE 
footprinting study wherein the HIV-1 gRNA was probed in virio in the presence and absence of 
bound NC (Wilkinson et al. 2008). These mutations were performed in a slightly different Ψ RNA 
construct than the one used in the present work. Nevertheless, we found that HIV-1 Gag binding 
to the Ψ-12M RNA was characterized by a ~25-fold weaker non-electrostatic binding component 
relative to WT Ψ RNA (Webb et al. 2013). We now report the results of individual mutations at 
each of these 6 regions (1-3 mutations per region, see Figure 3A and 3B). Mutation of two G-rich 
bulges in SL1 (Ψ-Mut 1 and 2) and single-stranded G residues downstream of SL3 (Ψ-Mut 6) 
displayed the largest loss in specificity (Figure 3), with the mutation in the upper single-stranded 
bulge of SL1 (Mut2) having a similar effect as previously reported for Psi-12M (~25-fold decrease 
in specificity) (Webb et al. 2013). Interestingly, this bulge together with the lower bulge in SL1 
(mutation of which reduces specificity ~10-fold in our assay) were found to be the two most 
statistically significant gRNA NC-interaction sites in the SHAPE study (Wilkinson et al. 2008). Our 
results are also consistent with a recent report identifying the upper bulge in SL1 (i.e., Ψ-Mut 2) 
as a critical site for full-length HIV-1 Gag interaction in vitro (Abd El-Wahab et al. 2014). Mutations 
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at 5 other locations in Ψ (Mut 3, 4, 5, 7, and 8) resulted in Gag binding specificity that was not 
distinguishable from Ψ-WT. Consistent with our results for Ψ-Mut 3, previous gRNA packaging 
studies found SL2 to be less important than the other elements of Ψ in directing gRNA 
incorporation into virions. (Kutluay et al. 2014, Lu et al. 2011, Keane et al. 2015, Abd El-Wahab 
et al. 2014, McBride and Panganiban 1996, McBride and Panganiban 1997). The Ψ-Mut 5 results 
were more surprising (~2-fold decrease in selectivity), as most studies agree on the importance 
of SL3 in packaging (Lu et al. 2011, McBride and Panganiban 1997). Importantly, mutation of a 
single-stranded G residue within Ψ that had not previously been implicated as a site of NC 
interaction (Ψ-Mut 7) did not negatively affect Gag binding specificity. Ψ-Mut 8 was the only HIV-
1 RNA mutant tested to modestly disrupt dimerization activity (Figure 3), but consistent with our 
early report (Webb et al. 2013), this does not impact Gag binding specificity of these ~100-nt 
constructs. While a recent mutational interference mapping study examining the RNA residues 
critical for HIV-1 Gag binding to Ψ (Smyth et al. 2015) did identify the region corresponding to Ψ-
Mut 8 as important, other studies are more consistent with a lack of direct Gag/NC binding in this 
region (Kutluay et al. 2014, Wilkinson et al. 2008). 
In summary, mutational analysis of guanosine residues within Psi tested using salt-
titration assays have indicated regions critical for Gag recognition. G residues in the bulges of SL1 
and the single-stranded regions downstream of SL3 were found to be integral for Gag 
recognition, consistent with most studies. We mapped these three most important sets of 
residues for promoting specific Gag binding onto a tertiary structural model of HIV-1 Ψ RNA 
generated by small-angle X-ray scattering (SAXS) (Figure 3B) (Jones et al. 2014). Interestingly, 
these mutations cluster together in the central part of the RNA. Since no single-site mutant 
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reduces Gag binding specificity to the level of TARpolyA, we propose that the clustering of several 
Gag interaction sites in close proximity is an important determinant of specific binding. 
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CHAPTER 2: HIV-1 5’UTR REGULATORY ELEMENTS MODULATE GAG∆P6 
BINDING SPECIFICITY 
INTRODUCTION 
Gag plays a crucial role within the HIV-1 lifecycle by facilitating the packaging of two 
copies of gRNA over other vsRNAs and cellular RNAs. Both genomic and virally spliced RNAs 
(vsRNAs) harbor the critical 5ʹUTR elements TAR, polyA, PBS, and SL1, differing in their sequences 
downstream of the major 5ʹ splice donor site within the hairpin loop of SL2. SL1 has been shown 
to be the main packaging determinant of gRNA, suggesting that vsRNAs avoid specific packaging 
through elements within their unique 3ʹ sequences downstream of the major 5ʹ splice site 
(Houzet et al. 2007). Further studies have hypothesized that a double regulatory mechanism 
within the HIV-1 5ʹUTR allow for specific selection of gRNA wherein a negative regulatory element 
that encompasses the TAR, polyA, and PBS stem loops, upstream of Psi, reduce high-affinity Gag 
binding, while a positive downstream regulatory element, only present in gRNA, counteracts the 
upstream element and restores high-affinity Gag binding (Abd El-Wahab et al. 2014) (Figure 5).  
 
FIGURE 5. Schematic of the 5ʹUTR double regulatory system flanking the four stem loops of Psi. Upstream of 
SL1 is the negative regulatory element, underlined with a red minus sign, and downstream of SL4 is the 
positive regulatory element, underlined with a green plus sign. Figure from (Abd El-Wahab et al. 2014). 
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Although this study made important findings regarding the elements of gRNA that are 
required for packaging, it did not directly address the mechanism of how these RNAs affect Gag 
in a manner that would facilitate their packaging. Gag has been shown to adopt two distinct 
conformations when binding to Psi RNA and non-Psi RNA using salt titration analysis (Webb et al. 
2013). Gag was shown to interact with Psi RNA in a linear conformation using primarily the NC 
domain while Gag interacted with non-Psi RNA in a bent conformation using both the NC and MA 
domains (Webb et al. 2013) (Figure 6).  
 
FIGURE 6. Model of Gag conformation upon binding to non-Psi and Psi RNAs. Gag binding to non-Psi RNAs is 
characterized in a NC and MA binding mode while Gag binds to Psi RNAs in an NC-only mode allowing it a kinetic 
advantage upon binding MA to the plasma membrane. Figure from (Webb et al. 2013). 
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Using the salt titration assay, we will test the hypothesis that Gag binds to RNAs 
containing the putative negative regulatory element and Psi stem loops in the bent conformation.  
In contrast, when binding to RNAs that contain the negative regulatory element, Psi, and the 
positive regulatory element, we hypothesize that Gag will to bind in a straight conformation 
similar to binding Psi alone.  
MATERIALS AND METHODS 
RNA PREPARATION 
Nine RNA constructs containing different lengths of the HIV-1 NL4-3 5ʹUTR were studied 
using direct FA binding assays and FA salt titration assays (Figure 7). For preparation Ψ-WT and 
TARpolyA RNA constructs, see “RNA preparation” in Chapter 1. The 228mer, 356mer, and 400mer 
RNA constructs were derived from the first 228, 356, and 400 nucleotides (nt) of the HIV-1 
genomic RNA, respectively. The Ψ+ construct contains nt 229–400 and the Omega (Ω) construct 
contains nt 356-400. Mutants of the 400mer construct were also used in this study wherein the 
last 44 nt of the RNA sequence were scrambled using a scramble function on an online Text 
Mechanic™ tool. This was performed twice, generating two mutants (400mer mut1 & mut 2). All 
RNAs were generated from plasmids encoding the T7 promoter sequence, the necessary RNA 
sequence, FokI restriction sites, and the Ampicillin resistance gene. Mutagenesis of plasmid 
constructs was performed using SLIM (Chiu et al. 2004).  
PROTEIN PREPARATION 
 A functional mutant of the Gag polyprotein with a truncated C-terminal p6 domain, 
Gag∆p6, was the primary protein used in this study and its more detailed preparation can be 
found in “Protein preparation” of Chapter 1.  
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FLUORESCENT RNA LABELING 
 All RNAs in this study were fluorescently labeled with FTSC at the 3ʹ position as described 
in Chapter 1: “Fluorescent RNA Labeling”. The concentration and labeling efficiency were 
determined by measuring the absorbance at 260 nm and 495 nm and using the following molar 
extinction coefficients: ε495nm = 8.5 × 104
 M−1·cm−1 (fluorescein), ε260nm = 9.7 × 105
 M−1·cm−1 (HIV-
1 Ψ WT), ε260nm = 9.3 × 105
 M−1·cm−1 (HIV-1 TARpolyA), ε260nm = 3.3 × 106
 M−1·cm−1 (HIV-1 356mer), 
ε260nm = 3.7 × 106
 M−1·cm−1 (HIV-1 400mer WT & 400mer mutants), ε260nm = 1.6 × 106
 M−1·cm−1 
(HIV-1 Ψ+), ε260nm = 3.7× 105
 M−1·cm−1 (HIV-1 Ω), and ε260nm = 2.1 × 106
 M−1·cm−1 (HIV-1 228mer).  
 
 
FIGURE 7. 5’UTR RNA Constructs used in this study. Dashed lines indicate scramble of the 44-nts in the putative 
positive regulatory element. Figure modified from (Abd El-Wahab et al. 2014).  
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DIRECT FA BINDING ASSAYS 
 Direct FA binding assays were first performed under the same conditions as described in 
“Direct FA binding assays” in Chapter 1 using all RNA constructs in Figure 7 with the exception of 
Ψ-WT and TARpoly A for which optimal protein concentrations have already determined (Webb 
et al. 2013, Rye-McCurdy et al. 2016). Optimal protein concentrations for each RNA were 
determined from direct FA binding assays by selecting near-saturating protein concentrations to 
minimize nucleic acid aggregation (Rye-McCurdy et al. 2015, Webb et al. 2013). Optimal Gag∆p6 
concentrations used for salt titration assays are as follows: 400 nM (HIV-1 Ψ-WT, Ψ+, TARpolyA), 
600 nM (HIV-1 228mer), 1000 nM (HIV-1 Ω, 356mer, 400mer WT, & 400mer mutants). Direct FA 
binding assays were not directly performed on the 400mer mutants, as we assumed the 
constructs would have similar affinity to Gag∆p6 as the 400mer WT. 
FA-BASED SALT TITRATION ASSAYS 
FA salt-titration binding assays were carried out using established protocols (Webb et al. 
2013, Rye-McCurdy et al. 2015). Assays were performed with 20.5 nM RNA in 20 mM HEPES, pH 
7.5, 2 mM Tris-HCl, 1 mM β-mercaptoethanol (βME), 1 mM MgCl2, and 50 mM NaCl with 400–
1000 nM HIV-1 Gag∆p6. All fluorescence measurements were performed on a SpectraMax M5 
plate reader (Molecular Devices, Sunnyvale, CA, USA).  
RESULTS AND DISCUSSION 
 In this study, we used Ψ-WT and TARpolyA as our controls for specific binding and non-
specific binding to Gag∆p6, respectively. Relative to previously published data (Webb et al. 2013, 
Rye-McCurdy et al. 2016), the Kd(1M) values measured here are approximately 10-fold less specific 
for both Ψ-WT and TARpolyA. Moreover, Ψ-WT bound with two more electrostatic contacts (Zeff 
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~7) relative to previous reports (Webb et al. 2013, Rye-McCurdy et al. 2016). Nevertheless, The 
difference in specificity between Ψ-WT and TARpolyA in this study was ~104, which is similar to 
previous results (Rye-McCurdy et al. 2016). 
Gag∆p6 binding to constructs that lack Ψ but contain the negative element alone (228mer 
construct) results in Kd(1M) and Zeff values that are increased compared to the 356mer construct, 
but overall binding specificity is not as diminished as for the TARpolyA construct. Strikingly, when 
testing the positive element alone (Ω construct), we observe the highest binding specificity of all 
of the RNA constructs in this study, as well as the lowest Zeff. The latter can be attributed to its 
short length at 44 nt. The secondary structure of Ω, predicted using an RNA secondary structure 
prediction program, Mfold (Zuker 2003), is shown in Figure 8. Based on this structure, the large 
number of single-stranded G residues, which are high-affinity NC binding sites, contributes 
greatly to the high binding specificity observed in this construct.  
 
 
 
 
 
 
 
FIGURE 8. Secondary structure prediction of HIV-1 Omega predicted by Mfold (∆G = -1.90 kcal/mol). RNA folding 
predicts 9 single-stranded G residues, which are high-affinity NC binding sites.  
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The 356mer, which consists of the putative negative regulatory element and SL1-SL4 of 
Ψ, results in only a modest increase in both the Kd(1M) and Zeff values when compared to the Ψ-
WT construct. The overall decrease in specificity in the 356mer is approximately 2-fold. When 
testing the 400mer WT construct, which consists of Ψ and both putative, flanking regulatory 
elements, we observe a decrease in both Kd(1M) and Zeff values is observed relative to both Ψ-WT 
and the 356mer, indicating more specific recognition by Gag∆p6 in the 400mer WT (Figure 9). 
Very similar parameters were measured for the Ψ+ construct, which contains SL1-SL4 of Ψ and 
the putative positive regulatory element. Thus, the addition of the positive element to both the 
356mer and Ψ-WT increases Gag∆p6 binding specificity both in the presence and absence of the 
negative element. 
 
 
FIGURE 9. Salt Titration Results of 5’UTR Wild Type RNAs. Bar graphs indicate Kd(1M) values and Zeff values 
determined from salt titration assays with HIV-1 Gag∆p6. Average values and standard deviations of triplicated 
experiments are shown in the table below.  
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 To further investigate the putative positive regulatory element and to establish whether 
its effect in conferring greater Gag binding specificity are sequence dependent, 400mer mutants 
were generated containing different scrambled 44-nt sequences that comprise the positive 
element. Salt titration analysis (Figure 10) revealed a two-fold decrease in the binding specificity 
between 400mer WT and 400mer mut 1 but no change between 400mer WT and 400mer mut 2. 
T-tests were used to compare the Kd(1M) and Zeff values of the 400mer WT and the mutants and 
no statistically significant differences were found (p ≮ 0.05) for either mutant. However, when t-
tests were performed to compare the 356mer and the 400mer mutants, statistically significant 
differences were found in both the Kd(1M) and Zeff values for 400mer mut 2 (p < 0.05). Overall, 
FIGURE 10. Salt Titration Results of the HIV-1 356mer, 400mer, and 400mer mutant RNAs. Bar graphs indicate 
Kd(1M) values and Zeff values determined from salt titration assays with HIV-1 Gag∆p6. P-values obtained from T-
tests between the 356mer and the 400mer mutants are shown by brackets followed by a “*” indicating p < 0.10 and 
“**” indicating p < 0.05. Average values and standard deviations of triplicated experiments are shown in the table 
below.  
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these data suggest that the putative positive regulatory element in the HIV-1 5ʹUTR functions 
independent of the sequence of nucleotides.  
Taken together, the data reported here do not provide evidence for interactions between 
the reported positive and negative regulatory elements in the HIV-1 5ʹUTR. Our data suggest that 
the positive regulatory element is able to increase Gag∆p6 binding specificity, independent of 
the negative regulatory element or its sequence. Given that sequences downstream of Psi, 
independent of sequence, are sufficient to facilitate an increase in Gag binding specificity, these 
results open up new questions into the mechanisms underlying genomic RNA packaging. In 
particular, the question of what elements within in the virally spliced RNAs disrupt their specific 
packaging into virions will be explored in the following chapter.  
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CHAPTER 3: SECONDARY STRUCTURE OF SPLICED HIV-1 TRANSCRIPTS REVEALS 
POTENTIAL MECHANISMS TO PREVENT PACKAGING.  
INTRODUCTION 
 The HIV-1 full-length RNA transcript is approximately 9-kb and encodes for 15-18 viral 
proteins from both full-length and alternatively-spliced transcripts. Full-length mRNA transcripts 
are selectively packaged into budding virions and are also translated to produce the Gag and Gag-
Pol proteins. Approximately half of the viral RNAs exported out of the nucleus are full-length 
transcripts (Stoltzfus 2009). Full length mRNA transcripts can be singly spliced, producing mRNA 
transcripts for the Vif, Vpr, Vpu, and Env proteins, or multiply spliced, producing the Rev, Tat, and 
Nef proteins. The proteins produced from multiply-spliced mRNAs are further characterized by 
their 1.8-kb transcript and their translation in the early phase of HIV-1 infection (Stoltzfus 2009). 
In contrast, the proteins produced from the singly-spliced transcripts are further characterized 
by their 4-kb transcript and their translation in the late phase of infection (Stoltzfus 2009). The 
HIV-1 5ʹUTR plays a significant role in the production of spliced viral mRNAs as it houses the major 
5ʹ splice site in SL2 used by both singly- and multiply- spliced transcripts. Thus, vsRNAs all contain 
identical 5ʹ sequences that include TAR, polyA, PBS, and SL1 and differ in sequences past the 
major 5ʹ splice site. These vsRNAs avoid specific packaging into budding virions by Gag despite 
harboring sequences like SL1, which have been shown to be necessary for efficient packaging 
(Aldovini and Young 1990, Houzet et al. 2007, Abd El-Wahab et al. 2014). We hypothesize that 
structural differences between vsRNAs and full-length gRNA in the 5ʹUTR may serve to block 
packaging of the former. To probe this idea, the secondary structure of the first 400 nt of the 
gRNA, as well as the first 400 nt of the Tat and Vpr mRNA transcripts, was determined using 
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selective 2ʹ hydroxyl acylation analyzed by primer extension (SHAPE).  
MATERIALS AND METHODS 
RNA PREPARATION 
 Four RNA constructs were used in this study: HIV-1 400mer wt, 400mer ∆DIS, Tat 400mer, 
and Vpr 400mer (Figure 11). Preparation of the 400mer wt construct can be found in “RNA 
Preparation” of Chapter 2. In the 400mer ∆DIS construct, the dimerization initiation signal 
(GCGCG) sequence in the loop of SL1 was replaced with a stable GAGA tetraloop to prevent RNA 
dimerization. Overlap extension PCR was performed on the 400mer wt plasmid to generate the 
mutation (Bryksin and Matsumura 2010). The Tat and Vpr 400mer constructs were designed from 
similar constructs found in (Bernacchi et al. 2017). Vpr 400mer is comprised of nt 1-290 of the 
HIV-1 NL4-3 genome and the first 110 nt of the Vpr exon. Tat 400mer is also comprised of nt 1-
290 of the HIV-1 NL4-3 genome but has the first 110 nt of the Tat exon. Plasmids containing the 
T7 promoter, RNA sequence of interest, FokI restriction cut sites, and Ampicillin resistance gene 
were designed and purchased from Integrated DNA Technologies, Inc. Subsequent RNA 
preparation steps can be found in “RNA preparation” Chapter 1.  
FLUORESCENT RNA LABELING 
 All RNAs in this study were fluorescently labeled with FTSC at the 3ʹ position as described 
in Chapter 1: “Fluorescent RNA Labeling”. The concentration and labeling efficiency were 
determined by measuring the absorbance at 260 nm and 495 nm and using the following molar 
extinction coefficients: ε495nm = 8.5 × 104
 M−1·cm−1 (fluorescein), ε260nm = 3.69 × 106
 M−1·cm−1 (HIV-
1 400mer WT, Vpr 400mer, and Tat 400mer), and ε260nm = 3.66 × 106
 M−1·cm−1 (HIV-1 400mer 
∆DIS). 
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SELECTIVE 2ʹ HYDROXYL ACYLATION ANALYZED BY PRIMER EXTENSION (SHAPE) 
 Unlabeled 400mer WT, Vpr 400mer, and Tat 400mer RNAs were probed using SHAPE 
(Wilkinson, Merino and Weeks 2006). RNAs were first folded as follows: 0.5 µg/µL RNA in 50 mM 
HEPES, pH 7.5, was heated at 80°C for 2 min, then 60°C for 2 min, and then MgCl2 was added to 
a final concentration of 10 mM, followed by incubation on ice for a minimum of 30 min. Folded 
RNAs were then added to 8 mM SHAPE reagent, N-methylisatoic anhydride (NMIA) resuspended 
in dimethyl sulfoxide (DMSO), or just DMSO at a final concentration of 100 ng/µL for 45 minutes 
at 37°C. Reactions were quenched by ethanol precipitation and the RNAs were pelleted. The 
reverse transcription reaction was then performed on the resuspended RNA pellet using 6-
carboxyfluorescein (6-FAM) labeled primers from Sigma-Aldrich and Superscript III reverse 
transcriptase. The reaction followed Invitrogen’s suggested protocol. Lastly, 1 µL of reverse 
transcribed product was ethanol precipitated and submitted to the Ohio State Plant-Microbe 
Genomics Facility for capillary electrophoresis (CE) analysis. CE data was then analyzed using 
Microsoft Excel-based tools developed by our lab called RiboCAT and RiboDOG (Cantara et al. 
FIGURE 11. RNA constructs used in this study. HIV-1 400mer ∆DIS is not shown in this figure. The purple lines 
downstream of the major 5’ splice site (SD1) indicate sequences from splice acceptor sites (SA2 & SA3) of Vpr and Tat.  
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2017). These tools simplify CE analysis and reduce manual intervention steps, allowing for a more 
precise output of overall SHAPE data (Cantara et al. 2017). After analysis, SHAPE reactivities are 
used as constraints to aid in the secondary structure folding of RNAs using RNAstructure 
(Mathews 2006).  
RESULTS AND DISCUSSION 
 The lowest energy secondary structure of the HIV-1 400mer WT construct folds in 
accordance with previously solved 5ʹUTR structures from both our lab and the Weeks lab 
(Cantara et al. 2017, Wilkinson et al. 2008) (Figure 12A). The TAR and polyA form independent 
hairpins followed by the PBS stem loop and SL1-SL3 of Psi. Given the differences observed in salt 
titration assays with Gag∆p6, we initially hypothesized that the secondary structure of the 
400mer WT would be different from the secondary structures formed from the 356mer construct 
solved in (Cantara et al. 2017). Similarities in the two 5ʹUTR structures can be explained by the 
fact that SHAPE data is unable to probe the most 5ʹ and 3ʹ ends due to high intensity peaks 
corresponding to the full-length transcript and reverse transcriptase stalling during initiation of 
primer extension (Wilkinson et al. 2006). Thus, in the case with the 400mer WT, SHAPE reactivity 
constraints are lacking for the last 40 nt. To address this issue, future SHAPE studies will be 
performed on a longer gRNA construct allowing proper data collection of the region immediately 
downstream of Psi.  
The SHAPE-derived secondary structure for the Vpr 400mer is shown in Figure 12B. 
Interestingly, while the TAR hairpin forms independently, the polyA hairpin base pairs with 
regions downstream of the major 5ʹ splice site, which are unique to the Vpr mRNA transcript. The 
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PBS region and SL1 maintain the same structure as the 400mer WT gRNA. The exact function of 
the polyA hairpin in the 5ʹUTR is not entirely clear, but structural studies have found that 
destabilization of the polyA hairpin produces defects in both, RNA packaging and viral replication 
(Clever, Eckstein and Parslow 1999, Das et al. 1997, Smyth et al. 2018). Moreover, the secondary 
structure of the polyA hairpin rather than the primary sequence was found to be an important 
component for specific packaging (Rye-McCurdy et al. 2016, Clever et al. 1999). In the lowest 
energy SHAPE-predicted structure, the polyA hairpin is stabilized by 5 Watson-Crick base pairs, 
whereas in the WT 400mer construct, the polyA hairpin is stabilized by 16 base pairs. This drastic 
destabilization of the hairpin and the lack of an independent hairpin downstream of the TAR stem 
loop potentially explains how this mRNA transcript avoids being specifically packaged.  
The SHAPE probed secondary structure of the Tat 400mer displays modest differences in 
TAR and polyA as compared to the 400mer WT RNA (Figure 12C). Although the hairpins are 
connected by an internal bulge, they maintain stable bases that stabilize their structure. In 
contrast, major changes are observed in the PBS domain. The PBS domain base pairs with 3ʹ 
regions unique to the Tat 400mer, in contrast to the largely single-stranded structure of the PBS 
domain adopted by the 400mer WT. Strikingly, the exact 18-nt PBS sequence where the primer 
for reverse transcription, tRNALys3, anneals is highly base paired and unreactive to the SHAPE 
reagent. The annealing of tRNALys3 to the 18-nt PBS has been shown to be mediated by the NC 
domain of Gag (Feng et al. 1999, Jones et al. 2013). The process of tRNA annealing may be 
disturbed in the Tat 400mer construct, due to a stabilized structure of the PBS. These 
conformational differences may prevent tRNA annealing, which may be a pre-requisite for RNA 
packaging.  
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FIGURE 12. Lowest energy secondary structures of: (A) 400mer WT, (B) Vpr 400mer, and (C) Tat 400mer with SHAPE 
reactivities. Secondary structures were plotted via RNAstructure. The red line in the secondary structures indicates 
the 18-nt PBS.  
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The overall global fold of the 400mer RNAs were assessed via native-PAGE to determine 
potential folding differences caused by the Vpr and Tat coding sequences downstream of the 
major 5ʹ splice site. The RNAs were run on a native-PAGE after the SHAPE reaction to properly 
assess their conformation in our SHAPE study (Figure 13). The 400mer WT forms two distinct 
bands with the major band corresponding to the dimer RNA and the minority band corresponding 
to the monomer. Identities of the monomer and dimer bands can be distinguished by comparison 
to the dimer-incompetent, 400mer ∆DIS monomer control. The Vpr 400mer forms a dominant 
FIGURE 13. Native-PAGE of fluorescently-labeled HIV-1 400mer WT, ∆DIS, & Vpr and Tat 400mers after SHAPE 
reaction. RNAs were labeled as described in the main text and folded as follows: 0.5 µg/µL RNA in 50 mM HEPES, pH 
7.5, was heated at 80°C for 2 min, then 60°C for 2 min, and then MgCl2 was added to a final concentration of 10 mM, 
followed by incubation on ice for a minimum of 30 min. SHAPE reactions were then performed on the RNAs both 
with (+) and without (-) NMIA. After the 45-minute SHAPE incubation at 37°C, Folded RNAs were run on a 4.5% 
native-polyacrylamide gel (19:1 acrylamide: bis-acrylamide) also containing 1 mM MgCl2 and TB (18 mM Tris, 9 mM 
borate, pH 8) at 4°C in TB running buffer. The final concentration HIV-1 RNA run on the gels shown was 83.25 ng/µL 
(617 nM) 2. Gels were visualized using the fluorescence mode on an AlphaImager EP (AlphaInnotech). 
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dimer band with very little monomer product. On the other hand, the Tat 400mer forms equal 
monomer and dimer bands. In all of these constructs, the DIS loop in SL1 is exposed and able to 
dimerize but other interactions may be affecting the ability of the 400mer WT and Tat 400mer to 
fully dimerize. Future studies will address this discrepancy by performing SHAPE reactions on 
dimer-incompetent (∆DIS) 400mer WT, Vpr 400mer, and Tat 400mer. 
Overall, our SHAPE studies of the 400-nt vsRNAs, Vpr and Tat, revealed structural 
differences compared to a 400-nt gRNA, 400mer WT. We explored the implication of these 
disrupted structures and their potential effect on specific packaging and concluded that each 
vsRNA construct that we studied has a potential mechanism by which it avoids specific packaging 
into virions. In the Vpr 400mer, we found that the polyA hairpin was destabilized, which has been 
shown to reduce gRNA packaging and viral replication. In the Tat 400mer, we found that the 18-
nt PBS was sequestered and unreactive, which may prevent tRNALys3 annealing. The exact step of 
the HIV-1 lifecycle when tRNA anneals is unknown but is has been proposed that annealing may 
be important for dimerization and packaging (Seif, Niu and Kleiman 2013).  
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CONCLUSIONS AND FUTURE DIRECTIONS 
In this thesis, the mechanisms by which Gag selects its genomic RNA for packaging were 
examined. Specific guanosine residues in Psi, larger flanking regulatory elements within the 
5ʹUTR, and spliced sequences ligated downstream of the major 5ʹ splice site were all probed. 
Guanosine residues in the internal bulge of SL1 and the single-stranded region downstream of 
SL3 diminished Gag binding specificity, consistent with other studies. Furthermore, guanosine 
residues in SL2 and SL3 were not significant at reducing overall Gag specificity. The data reported 
here provide weak evidence in support of previously proposed upstream negative regulatory 
element, but sequences downstream of Psi are able to increase Gag∆p6 binding specificity 
independent of the upstream element and its sequence. Since downstream sequences were 
sufficient to increase Gag specificity, how segments of vsRNAs that encode for Vpr and Tat avoid 
specific packaging was examined. SHAPE probing allowed us to solve the secondary structures of 
our vsRNA constructs, revealing potential anti-packaging mechanisms that rely on restructuring 
of important regulatory elements. Overall, these studies have furthered our insight into the 
complexity of genomic RNA packaging.  
In our future studies, we plan to continue exploring the Vpr and Tat 400mer constructs 
by performing salt titration assays with Gag∆p6, comparing their behavior to the 400mer WT. 
This will allow us to determine their overall Gag binding specificity, as well as the conformation 
in which Gag is binding to these RNAs. This will also directly address our hypothesis on the polyA 
hairpin destabilization in the Vpr 400mer construct and whether that impacts specific recognition 
by Gag. To address our hypothesis about the sequestered PBS in the Tat 400mer construct, we 
plan on performing NC-mediated tRNALys3 annealing assays to determine differences in the ability 
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of NC to anneal tRNALys3 to this construct and the 400mer WT.  
Lastly, we plan on studying the effect of trans-acting elements on the 5ʹUTR and how they 
affect specific recognition by Gag. We are particularly interested in how tRNALys3 modulates the 
structure of the 5ʹUTR upon annealing. Current literature suggests that annealing of tRNALys3 to 
the PBS promotes dimerization of the RNA, which is then favored for packaging (Seif et al. 2013). 
Preliminary heat annealing assays suggests that dimerization is favored, but only slightly. To 
explore this further, we plan to perform NC-mediated annealing to properly assess the promotion 
of a specific conformational state. Furthermore, we plan to perform salt titration assays to 
determine Gag specificity.  
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